Nicole Germino
Stock Analyst at Truist Securities
(0.27)
# 2526
Out of 5,329 analysts
28
Total ratings
28.57%
Success rate
-4.29%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CATX Perspective Therapeu... | Maintains: Buy | 21 10 | 2.46 | 306.5% | 2 | Apr 7, 2025 | |
YMAB Y-mAbs Therapeutics | Maintains: Buy | 21 18 | 4.1 | 339.02% | 2 | Mar 5, 2025 | |
INSM Insmed | Maintains: Strong Buy | 105 108 | 72.77 | 48.41% | 8 | Feb 21, 2025 | |
SGMO Sangamo Therapeutics | Maintains: Buy | 7 5 | 0.74 | 575.68% | 5 | Jan 23, 2025 | |
FUSN Fusion Pharmaceutica... | Downgrades: Hold | 11 21 | n/a | n/a | 3 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 13 13 | n/a | n/a | 3 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 132 24 | 11.44 | 109.79% | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Sep 3, 2021 |